Docosahexaenoic Acid and Childhood Blood Pressure
Issue Date
2018-05-31Author
Littrell, Juleah
Publisher
University of Kansas
Format
41 pages
Type
Thesis
Degree Level
M.S.
Discipline
Dietetics & Nutrition
Rights
Copyright held by the author.
Metadata
Show full item recordAbstract
Background: Long chain polyunsaturated fatty acids (LCPUFAs) have been shown to reduce blood pressure (BP) while they are being consumed; however, there is also evidence from observational studies that exposure to more LCPUFA early in development can program lower BP in childhood. This relationship has yet to be studied in a randomized trial conducted during fetal life. Objective: We tested the hypothesis that 600 mg/d of the omega-3 LCPUFA docosahexaenoic acid (DHA) compared to placebo in pregnancy can reduce offspring BP at 7 and 8 years of age. Methods: This secondary data analysis examines 129 offspring from women who consumed capsules (placebo or 600 mg DHA) from <20 weeks of gestation to birth. BP was measured in triplicate at 7 and 8 years of age. The statistical analysis was intent-to-treat with adjustment for covariates associated with BP. Results: We did not find an effect of early DHA exposure on BP, however, child weight status (BMI percentile < or ≥85th percentile) and gestational days smoked were positively associated with BP at 7 and 8 years of age. Conclusion: Improving maternal and therefore fetal DHA status through maternal DHA supplementation during pregnancy does not appear to protect against higher BP at 7 and 8 years of age.
Collections
- KU Med Center Dissertations and Theses [464]
- Theses [3942]
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.